A Phase II Study of Arsenic Trioxide (NSC 706363) in Patients With Advanced Adenocarcinoma of the Esophagus or Gastroesophageal Junction
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 30 Jan 2013 New trial record